Home › Funds › Viking Global Investors › IMVT
Viking Global Investors position in IMVT
IMMUNOVANT INC · Health Care
Latest position (Q1 2025)1.11M sh
Reported value held$19.05M
Portfolio Weight0.06%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 1.81M | $58.45M | New |
| Q2 2024 | 2.32M | $61.27M | Add |
| Q3 2024 | 2.32M | $66.17M | Hold |
| Q4 2024 | 1.41M | $34.86M | Reduce |
| Q1 2025 | 1.11M | $19.05M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IMVT
- Fidelity Management & Research (FMR) 16.19M sh · $623.66M · Q2 2026
- BlackRock Inc 7.18M sh · $276.68M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- Vanguard Group 7.78M sh · $197.75M · Q4 2025
- Morgan Stanley 4.53M sh · $174.73M · Q2 2026
- Geode Capital Management 2.23M sh · $86.12M · Q2 2026
- Goldman Sachs Group 1.75M sh · $67.47M · Q2 2026
- D. E. Shaw & Co 1.24M sh · $47.80M · Q2 2026
- Bank of America Corp 1.18M sh · $45.52M · Q2 2026
- Northern Trust Corp 794.00K sh · $30.59M · Q2 2026
- Renaissance Technologies 726.80K sh · $28.00M · Q2 2026
- Charles Schwab Investment Management 680.59K sh · $26.22M · Q2 2026